GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Response Oncology Inc (GREY:ROIX) » Definitions » Interest Expense

Response Oncology (Response Oncology) Interest Expense : $-0.3 Mil (TTM As of Mar. 2002)


View and export this data going back to 1989. Start your Free Trial

What is Response Oncology Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Response Oncology's interest expense for the three months ended in Mar. 2002 was $ -0.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2002 was $-0.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Response Oncology's Operating Income for the three months ended in Mar. 2002 was $ 0.1 Mil. Response Oncology's Interest Expense for the three months ended in Mar. 2002 was $ -0.3 Mil. Response Oncology's Interest Coverage for the quarter that ended in Mar. 2002 was 0.37. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Response Oncology Interest Expense Historical Data

The historical data trend for Response Oncology's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Response Oncology Interest Expense Chart

Response Oncology Annual Data
Trend Dec92 Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -3.31 -3.68 -2.42

Response Oncology Quarterly Data
Jun97 Sep97 Dec97 Mar98 Jun98 Sep98 Dec98 Mar99 Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.99 - - - -0.32

Response Oncology Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2002 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Response Oncology  (GREY:ROIX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Response Oncology's Interest Expense for the three months ended in Mar. 2002 was $-0.3 Mil. Its Operating Income for the three months ended in Mar. 2002 was $0.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2002 was $0.0 Mil.

Response Oncology's Interest Coverage for the quarter that ended in Mar. 2002 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2002 )/Interest Expense (Q: Mar. 2002 )
=-1*0.12/-0.323
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Response Oncology (Response Oncology) Business Description

Traded in Other Exchanges
N/A
Address
1775 Moriah Woods Boulevard, Memphis, TN, USA, 38117
Website
Response Oncology Inc provides cancer treatments and related services on an outpatient basis.

Response Oncology (Response Oncology) Headlines

No Headlines